Aims and Scope of Human Molecular Genetics
Human Molecular Genetics, first published in 1992, is a semimonthly peer reviewed, scientific journal, published by The Oxford University Press. The journal's focus is research papers on all topics related to human molecular genetics. In addition, two "special review" issues are published each year. There are four professors who share the title of Executive Editor for this journal: Professor Kay Davies from the University of Oxford, Professor Anthony Wynshaw-Boris from Case Western Reserve University, Timothy M. Frayling from the University of Exeter, and Eleftheria Zeggini from Helmholtz Zentrum München. Less
Key Metrics
CiteScore 

10.3
Eigenfactor 

0.01 - 0.05
Impact Factor 

< 5
Scite Index 

0.92 5-Year SI

SJR 

Q1Genetics

SNIP 

1.38
Recommended pre-submission checks
Powered by 

Topics Covered on Human Molecular Genetics
Human Molecular Genetics Journal Specifications
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 1992 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Human Molecular Genetics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Human Molecular Genetics
Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss
- 17 Jun 2026
- Human Molecular Genetics
Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.
- 12 Jun 2026
- Human molecular genetics
Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.
- 12 Jun 2026
- Human molecular genetics
Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.
- 12 Jun 2026
- Human molecular genetics
Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.
- 12 Jun 2026
- Human molecular genetics
Disease-specific biomarkers of pathogenic HRAS variants in human immortalized keratinocytes.
- 9 Jun 2026
- Human molecular genetics
Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss
- 17 Jun 2026
- Human Molecular Genetics
Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.
- 12 Jun 2026
- Human molecular genetics
Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.
- 12 Jun 2026
- Human molecular genetics
Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.
- 12 Jun 2026
- Human molecular genetics
Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.
- 12 Jun 2026
- Human molecular genetics
Disease-specific biomarkers of pathogenic HRAS variants in human immortalized keratinocytes.
- 9 Jun 2026
- Human molecular genetics